MedTrace Logo

ClearPath DS-120 Clinical Study Protocol

NCT01425346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2011-08-30

No results posted yet for this study

Summary

The goal of this study is to measure lens fluorescence in normal subjects at various chronological ages that could serves as a guide to clinicians in determining changes in eye health. A measure of lens fluorescence can be used by clinicians as an indication of degenerative changes occurring in the lens of the eye.

Conditions

  • Ophthalmic, Healthy Eyes

Sponsors & Collaborators

  • Freedom Meditech

    lead INDUSTRY

Principal Investigators

  • Stephen W. Lum, O.D. · San Diego Optometry Practice

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01425346 on ClinicalTrials.gov